MeiraGTx Holdings (MGTX) Total Debt (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Total Debt came in at $49.7 million in Q4 2025, down 32.14% YoY from $73.2 million in Q4 2024, and down 32.65% on a QoQ basis from $73.8 million in Q2 2025.
MeiraGTx Holdings (MGTX) Total Debt (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 6 years of Total Debt data on file, last reported at $49.7 million in Q4 2025.
- Quarterly Total Debt fell 32.14% year-over-year to $49.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.7 million (down 32.14% YoY) and the FY2025 annual result came in at $49.7 million, down 32.14% from the prior year.
- Total Debt slipped to $49.7 million in Q4 2025, from $73.8 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $73.8 million in Q2 2025 to a low of $208000.0 in Q1 2023.
- A 5-year average of $48.6 million and a median of $71.7 million in 2023 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt slumped 72.51% — and 2024, when it surged 34703.37%.
- Tracing MGTX's Total Debt over 5 years: stood at $953000.0 in 2021, then tumbled by 72.51% to $262000.0 in 2022, then jumped by 27426.34% to $72.1 million in 2023, then grew by 1.53% to $73.2 million in 2024, then plunged by 32.14% to $49.7 million in 2025.
- The last three Total Debt figures came in at $49.7 million (Q4 2025), $73.8 million (Q2 2025), and $73.5 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 49.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.69 Mn |
| Jun 30, 2025 | 73.77 Mn |
| Mar 31, 2025 | 73.50 Mn |
| Dec 31, 2024 | 73.22 Mn |
| Sep 30, 2024 | 72.94 Mn |
| Jun 30, 2024 | 72.67 Mn |
| Mar 31, 2024 | 72.39 Mn |
| Dec 31, 2023 | 72.12 Mn |
| Sep 30, 2023 | 71.84 Mn |
| Jun 30, 2023 | 71.57 Mn |
| Mar 31, 2023 | 208,000.00 |
| Dec 31, 2022 | 262,000.00 |
| Sep 30, 2022 | 70.85 Mn |
| Jun 30, 2022 | 304,000.00 |
| Mar 31, 2022 | 556,000.00 |
| Dec 31, 2021 | 953,000.00 |
| Dec 31, 2017 | 861,030.00 |